1 year return (CAGR)
44.55%
Verve Therapeutics Inc Exchange (NASDAQ, USD)
VERV
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-32.33%
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
994.04M
Price/Sales
40.75
Ent value
990.69M
Price/Book
1.95
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 11.13 |
| Daily high | 11.13 |
| Daily low | 11.13 |
| Daily Volume | 0K |
| 1y analyst estimate | 13.13 |
| Beta | 2.24 |
| EPS (TTM) | -2.33 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| VERV | S&P500 | |
| Current price drop from All-time high | -84.96% | -0.59% |
| Highest price drop | -95.99% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -72.57% | -10.68% |
| Avg time to new high | 74 days | 12 days |
| Max time to new high | 972 days | 1805 days |
News
No items found